Delivery Order SPE2DB24D2101-SPE2DB24FKFWU

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA). The $4,731.94 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs,...
This federal contract award is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS to the Defense Logistics Agency (DLA), a defense agency. The $5,370.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a completion date of October 29, 2024. This order is a part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,237.41, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of January 23, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.12 firm fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication used for various medical treatments. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Lupron Depot 3.75 mg kits to the Defense Logistics Agency (DLA). The $12,115.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Lupron Depot 45 mg 6-month kits to the U.S. government. The $6,373.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA). The $29,571.84 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management. The contract has an ultimate completion date of March 1, 2024 and was awarded on February 29, 2024. It is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lupron Depot 11.25 mg 3-month kits. The contract has a ceiling value of $34,831.45 and runs through March 4, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,836.72, is a delivery order for the supply of Lupron Depot 11.25 mg 3-month kits. The contract has a completion date of January 6, 2025 and uses a firm fixed-price pricing type. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery...
This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA), a defense agency. The $32,112.38 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distributor. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, enabling the efficient procurement of a...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFWU
    Delivery Order

This contract award is for the supply of Lupron Depot 11.25 mg 3-month kits to the Defense Logistics Agency (DLA), a major defense agency. The $10,022.42 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, with no set-aside designation. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen holds significant indefinite delivery contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to provide a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare needs nationwide.

Generated 11/13/24, 9:28 AM